(Q36882923)

16 August 2017

Causality assessment of serious neurologic adverse events following 2009 H1N1 vaccination (English)

1 reference

16 August 2017

7

Nicola P Klein

1 reference

16 August 2017

20

Kathryn M Edwards

1 reference

16 August 2017

18

James J Sejvar

1 reference

16 August 2017

3

Claudia Vellozzi

1 reference

16 August 2017

5

Cornelia L Dekker

1 reference

16 August 2017

10

Philip S Larussa

1 reference

16 August 2017

S Elizabeth Williams

1

1 reference

16 August 2017

Barbara A Pahud

2

1 reference

16 August 2017

Peter D Donofrio

4

1 reference

16 August 2017

Neal Halsey

6

1 reference

16 August 2017

Roger P Baxter

8

1 reference

16 August 2017

Colin D Marchant

9

1 reference

16 August 2017

Elizabeth D Barnett

11

1 reference

16 August 2017

Jerome I Tokars

12

1 reference

16 August 2017

Brian E McGeeney

13

1 reference

16 August 2017

Robert C Sparks

14

1 reference

16 August 2017

Laurie L Aukes

15

1 reference

16 August 2017

Kathleen Jakob

16

1 reference

16 August 2017

Silvia Coronel

17

1 reference

16 August 2017

Barbara A Slade

19

1 reference

16 August 2017

language of work or name

English

0 references

publication date

3 September 2011

1 reference

16 August 2017

1 reference

16 August 2017

29

1 reference

16 August 2017

46

1 reference

16 August 2017

8302-8308

1 reference

Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860884

Estimating background rates of Guillain-Barré Syndrome in Ontario in order to respond to safety concerns during pandemic H1N1/09 immunization campaign

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860884

Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860884

Resistance to vaccination: the attitudes and practices of primary healthcare workers confronting the H1N1 pandemic

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860884

Healthcare workers as parents: attitudes toward vaccinating their children against pandemic influenza A/H1N1.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860884

The prevalence of multiple sclerosis in 3 US communities

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860884

Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860884

Revisiting the possibility of serious adverse events from the whole cell pertussis vaccine: were metabolically vulnerable children at risk?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860884

Serious adverse events rarely reported after trivalent inactivated influenza vaccine (TIV) in children 6-23 months of age.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860884

Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860884

Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860884

Guillain-Barré syndrome following influenza vaccination

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860884

Immunization and MS: a summary of published evidence and recommendations

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860884

The science of evaluation of adverse events associated with vaccination

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860884

Monitoring signals for vaccine safety: the assessment of individual adverse event reports by an expert advisory committee. Advisory Committee on Causality Assessment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860884

A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860884

Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860884

Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860884

Identifying and addressing safety signals in clinical trials

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860884

The role of the Vaccine Adverse Event Reporting system (VAERS) in monitoring vaccine safety

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860884

Preceding infections, immune factors, and outcome in Guillain-Barré syndrome

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860884

Portrait of a year-old pandemic

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860884

Acute neurological events associated with influenza vaccination: are the WHO criteria for assessing causality adequate?

20 October 2018

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.093

10.1016/J.VACCINE.2011.08.093

7 January 2021

Identifiers

DOI

1 reference

16 August 2017

1 reference

16 August 2017

1 reference